Young Gil Ahn

Title: **Innovator Spotlight: Young Gil Ahn**

Introduction

Young Gil Ahn, a notable inventor located in Seongnam-si, South Korea, has made significant contributions to the field of pharmaceuticals, amassing a total of 18 patents throughout his career. His innovative work focuses on developing new compounds with therapeutic potential, showcasing the impact of his research on modern medicine.

Latest Patents

Among his latest patents are the following:

1. **Salts of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide, and crystalline forms thereof** - This invention describes a crystalline form of a salt of the compound, highlighting its usefulness in preparing pharmaceutical compositions where it acts as an active ingredient.

2. **Dioxoloisoquinolinone derivatives and use thereof** - This patent discloses novel dioxoisoquinolinone derivative compounds and their pharmaceutically acceptable salts. These compounds are noted for their potential to inhibit the enzymatic activity of EZH1 and EZH2, crucial markers in various diseases.

Career Highlights

Young Gil Ahn has made an impressive mark within the pharmaceutical industry, particularly through his affiliations with Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His work in these companies has paved the way for advancements in drug development and therapeutic innovations.

Collaborations

Throughout his career, Young Gil Ahn has collaborated with esteemed colleagues such as In Hwan Bae and Kwee Hyun Suh. These partnerships have undoubtedly enriched his research endeavors and contributed to the successful fruition of many of his patented inventions.

Conclusion

With 18 patents to his name, Young Gil Ahn exemplifies the spirit of innovation in the pharmaceutical sector. His latest inventions signify a remarkable commitment to advancing healthcare solutions and improving patient outcomes, establishing him as a leading figure among contemporary inventors in the field.